En Español

Pharmaceutical Industry Services

These services include iPSC and iPSC-derived cell production for the pharmaceutical industry, such as generating cell models for testing drug efficacy and toxicity, among others.

This application of great potential and growth seeks to allow companies to test toxicity profiles of pipeline products in hepatocytes, cardiomyocytes and/or neurons obtained from the general population or from patients suffering from specific conditions. Likewise, they will be able to evaluate efficacy in cell panels affected by the pathology of interest.